New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells

International Journal of Oncology

Volumn 40, Issue 6, 2012, Pages 1977-1985

  Cao, Kai Yuan ^a,b,c   Xu, Lin ^b,c   Zhang, Ding Mei ^b,c   Zhang, Xiao Ming ^b   Zhang, Tian ^b   He, Xia ^b   Wang, Zhu ^b   Feng, Fa Shen ^b   Qiu, Shao Peng ^c   Shen, Guan Xin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Prostate cancer; Prostate specific membrane antigen; PSM E; RNA interference; Splice variant

Indexed keywords

PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROSTATE SPECIFIC MEMBRANE E ANTIGEN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL COUNT; CELL MIGRATION; CONTROLLED STUDY; DNA SEQUENCE; DNA VECTOR; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIGENS, SURFACE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS;

EID: 84861765675     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1358     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Murry T, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 57: 43-66, 2007.
2. Nelson WG, De Marzo AM and Isaacs WB: Prostate cancer. N Engl J Med 349: 366-381, 2003. (Pubitemid 36886244)
3. Israeli RS, Powell CT, Fair WR and Heston WD: Molecular cloning of a complementary DNA encoding a prostate-specific membrane. Cancer Res 53: 227-230, 1993. (Pubitemid 23031827)
4. Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM and Isaacs JT: Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Prostate 54: 249-257, 2003. (Pubitemid 36228161)
5. Karan D, Kelly DL, Rizzino A, Lin MF and Batra SK: Expression profile of differentially regμlated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis 23: 967-975, 2002. (Pubitemid 34752952)
6. Lapidus, RG, Tiffany, CW, Isaacs, JT and Slusher BS: Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells. Prostate 45: 350-354, 2000.
7. Ross JS, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, Gray K, Webb I, Gray GS, Mosher R and Kallakury BV: Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res 9: 6357-6362, 2003. (Pubitemid 38031820)
8. Ghosh A and Heston WD: Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 91: 528-539, 2004.
9. Kinoshita Y, Kuratsukuri K, Landas S, Imaida K, Rovito PM Jr, Wang CY and Haas GP: Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J Surg 30: 628-636, 2006.
10. O'Keefe DS, Bacich DJ and Heston WD: Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene. Prostate 58: 200-210, 2004. (Pubitemid 38160908)
11. Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS and Gaudin PB: Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor- associated neovasculature. Cancer Res 59: 3192-3198, 1999. (Pubitemid 29316022)
12. Chang SS, Reuter VE, Heston WD and Gaudin PB: Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen. Urology 57: 801-805, 2001.
13. Liu T, Jabbes M, Nedrow-Byers JR, Wu LY, Bryan JN and Berkman CE: Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium. Int J Oncol 38: 1349-1355, 2011.
14. Ma Q, Safar M, Holmes E, Wang Y, Boynton AL and Junghans RP: Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy. Prostate 61: 12-25, 2004. (Pubitemid 39095692)
15. Dhar S, Kolishetti N, Lippard SJ and Farokhzad OC: Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci USA 108: 1850-1855, 2011.
16. Keren H, Lev-Maor G and Ast G: Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet 11: 345-355, 2010.
17. Kalnina Z, Zayakin P, Silina K and Line A: Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer 42: 342-357, 2005. (Pubitemid 40271278)
18. Su SL, Huang IP, Fair WR, Powell CT and Heston WD: Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res 55: 1441-1443, 1995.
19. Cao KY, Mao XP, Wang DH, Xu L, Yuan GQ, Dai SQ, Zheng BJ and Qiu SP: High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen. Prostate 67: 1791-1800, 2007. (Pubitemid 350228731)
20. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R and Shoemaker DD: Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141-2144, 2003. (Pubitemid 38017950)
21. Casado-Vela J, Cebrian A, del Pulgar MT, Sanchez-Lopez E, Vilaseca M, Menchen L, Diema C, Selles-Marchart S, Martinez-Esteso MJ, Yubero N, Bru-Martinez R and Lacal JC: Lights and shadows of proteomic technologies for the study of protein species including isoforms, splicing variants and protein post-translational modifications. Proteomics 11: 590-603, 2011.
22. O'Keefe DS, Bacich DJ and Heston WD: Prostate specific membrane antigen. In: Prostate Cancer, Biology, Genetics, and the New Therapeutics. Chung LWK, Issacs WB, Simons JW (edit). Humana Press, Totowa, NJ, pp307-326, 2001.
23. Mlcochova P, Barinka C, Tykvart J Sacha P and Konvalinka J: Prostate-specific membrane antigen and its truncated form PSM'. Prostate 69: 471-479, 2009.
24. Schmittgen TD, Teske S, Vessella RL, True LD and Zakrajsek BA: Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. Int J Cancer 107: 323-329, 2003. (Pubitemid 37152918)
25. Rawlings ND and Barrett AJ: Structure of membrane glutamate carboxypeptidase. Biochem Biophys Acta 1339: 247-252, 1997. (Pubitemid 27220250)
26. Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213, 2002. (Pubitemid 34969582)
27. Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X and Xu DQ: Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Clin Cancer Res 11: 6333-6341, 2005. (Pubitemid 41262965)
28. Shen HL, Xu W, Wu ZY, Zhou LL, Qin RJ and Tang HR: Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells. Leuk Res 31: 515-521, 2007. (Pubitemid 46198943)
29. Ghosh A, Wang XN, Klein E and Heston WD: Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness. Cancer Res 65: 727-731, 2005. (Pubitemid 40216430)
30. Lee JH, Seo YW, Park SR, Kim YJ and Kim KK: Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res 63: 7247-7255, 2003. (Pubitemid 37413464)
31. Schiilke N, Varlamova OA, Donovan GP, Ma D, Gardner JP, Morrissey DM, Arrigale RR, Zhan C, Chodera AJ, Surowitz KG, Maddon PJ, Heston WD and Olson WC: The homodimer of prostate-specific membrane antigen is a function target for cancer therapy. Proc Natl Acad Sci USA 22: 12590-12591, 2003.
32. Williams T and Kole R: Analysis of prostate-specific membrane antigen splice variants in LNCap cells. Oligonucleotides 16: 186-195, 2006.